Potrero Medical Announces Restructuring and Continued Operations
HAYWARD, Calif., Dec. 1, 2023 /PRNewswire/ -- Potrero Medical, Inc. ("Potrero" or the "Company") announced today that it has begun a voluntary restructuring of its finances by filing a pre-negotiated petition for relief under Chapter 11 of the U.S. Bankruptcy Code. The restructuring is expected to be completed in less than 75 days.
The Company believes that this voluntary reorganization will bolster its finances and facilitate its ongoing focus on elevating patient care.
Keller Benvenutti Kim is serving as legal counsel to Potrero, and G2 Capital Advisors is serving as financial advisor.
Additional information about the bankruptcy case may be obtained by visiting https://cases.stretto.com/Potreromedical or by calling the case information line at 888.959.4846 (Toll-Free) or 949.749.2218 (International).
About Potrero: Potrero Medical, Inc. is a medical device platform transforming patient care through precision fluid management and analytics that offer clinical decision support by providing precise data from the kidney. Potrero Medical was founded with a mission to improve patient care and save health systems money with the latest advances in artificial intelligence and sensors.?Potrero Medical is headquartered in?Hayward, CA.?For more information, visit?www.potreromed.com.
United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, will unveil its latest MRI technology, boasting incredible advancements across various fronts, as a Gold sponsor at this year's ISMRM meeting.
The...
In the news release, Mitsubishi Tanabe Pharma America to Present RADICAVA ORS® (edaravone) Real-World Data at the Professional Society for Health Economics and Outcomes Research 2024 Annual Meeting, issued 03-May-2024 by Mitsubishi Tanabe Pharma...
Affiliated Dermatologists (AD) is providing notice of a recent data security incident. At this time, AD is not aware of any misuse of any personal information in connection with this incident.
What Happened?
On March 5, 2024, AD detected it was the...
With recent news of dairy cattle in the United States testing positive for the Highly Pathogenic Avian Influenza (HPAI) and reports of fragments of HPAI detected in pasteurized milk sold in the U.S., we understand that Canadians may be concerned...
Butterfly Medical Ltd, an early-stage medical device company focused on alleviating suffering in patients with BPH (Benign Prostatic Hyperplasia), is excited to announce the hiring of Patrick MacCarthy as CEO. ...
BioVaxys Technology Corp. (FRA: 5LB) (the "Company") is pleased to announce that it has closed the first tranche (the "First Tranche") of its previously announced non-brokered private placement (the "Private Placement") with the issuance of...
